Vaporous Hyperoxia Therapy (VHT) in the Treatment of Foot Wounds

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

31 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-06-06

Study Completion Date

2007-10-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effectiveness of Vaporous Hyperoxia Therapy (VHT), previously named Misty (WTS-1000) for the treatment of chronic foot ulcers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness of Vaporous Hyperoxia Therapy (VHT) in the Treatment of Chronic Diabetic Foot Ulcers

NCT04210609

Diabetic Foot Ulcer

UNKNOWN NA

MIST Ultrasound Therapy Compared to United Kingdom Standard Care for the Treatment of Non-healing Venous Leg Ulcers

NCT01671748

Varicose Ulcer

COMPLETED NA

Extracorporeal Shockwave Therapy for Diabetic Foot Wounds

NCT04042285

Diabetic Foot Wound

COMPLETED

A Study Comparing V.A.C. Negative Pressure Wound Therapy (NPWT) to Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Amputation Wounds

NCT00837096

Diabetic Amputation Foot Wound

TERMINATED NA

Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol

NCT02045303

Chronic Ulcer of Lower Extremity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Vaporox VHT1 study is a single arm study evaluating the efficacy of Vaporous Hyperoxia Therapy (VHT), previously named Misty (WTS-1000), as an adjunctive therapy for the treatment of chronic foot ulcers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuropathic Foot Ulcer Foot Ulcer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

VHT treatment

Patients will be treated with VHT for 1 hour four times per week

Group Type EXPERIMENTAL

Vaporous Hyperoxia Therapy

Intervention Type DEVICE

1 hour of treatment, 4 times per week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vaporous Hyperoxia Therapy

1 hour of treatment, 4 times per week

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

VHT Misty WTS

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diabetic, arterial, and venous foot ulcers as well as decubitus ulcers
* University of Texas Health Science Center classification: Grade 0, 1, and 2

Exclusion Criteria

* Ulcers above the medial and lateral malleoli
* Etiology of cancer/neoplastic
* Etiology of collagen vascular disease
* Etiology of gangrene
* Etiology of osteomyelitis (Grade 3)
* Etiology of thermal burns
* Etiology of radiation injury
* Pregnancy
* Acute skin conditions
* Inadequate perfusion to support treatment
* Wounds where the end cannot be probed
* Wounds covered with petroleum based dressing
* Non-compliant patients

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No